Cannabis and Psychosis

West, Michael O.; Sharif, Shadi

doi:10.1016/j.chc.2022.07.004

Cited by 5 publications

(5 citation statements)

References 60 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The exclusion criteria encompassed the presence of severe withdrawal symptoms persisting throughout the entire treatment duration, thus rendering a diagnosis of ADHD unfeasible. Additionally, conditions resulting in significant cognitive deficits, such as Korsakoff syndrome or acute psychosis, led to exclusion [ 16 , 42 ].…”

Section: Methodsmentioning

confidence: 99%

“…Both physical and psychiatric comorbidities play crucial roles in shaping the trajectory of SUDs [ 13 ]. Psychiatric ailments often precipitate self-medication practices, potentially exacerbating primary condition symptoms or instigating additional psychiatric comorbidities, like substance-induced psychosis [ 14 , 15 , 16 ]. Furthermore, psychiatric disorders characterized by heightened impulsivity, such as borderline personality disorder (BPD) and attention deficit hyperactivity disorder (ADHD), can impede treatment adherence, hindering efforts to address SUDs effectively [ 17 , 18 , 19 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Attention Deficit Hyperactivity Disorder: A Risk Factor for Premature Discontinuation of Inpatient Opioid Withdrawal Treatment

Gaspar,

Kilarski,

Rosen

et al. 2024

JCM

View full text Add to dashboard Cite

Background: Substance use disorders present a tremendous challenge within contemporary healthcare systems. Specifically, in the domain of opioid use disorders (OUDs), several foundational elements are crucial for the efficacious management of afflicted individuals. Regrettably, the premature discontinuation of inpatient opioid withdrawal treatment is a prevalent phenomenon. This study aims to elucidate the prevalence of the premature termination of inpatient opioid withdrawal treatment among patients with comorbid ADHD. Methods: We conducted a comprehensive assessment of all participants currently undergoing inpatient opioid withdrawal treatment. Our assessment protocol included the administration of the ADHD Self-Report Scale (ADHD-SR) and the Wender Utah Rating Scale (WURS-k). Additionally, participants who met the thresholds on one or both questionnaires underwent further evaluation using the Diagnostic Interview for ADHD in Adults (DIVA-2.0). Results: The prevalence of individuals diagnosed with ADHD within the studied cohort was determined to be 29.3%. Among the subset of participants identified as ADHD-positive, a notable 54.5% prematurely ceased therapy. In contrast, among those identified as ADHD-negative, the premature discontinuation rate was substantially lower at 28.3%. Conclusions: In summary, the impact of ADHD as a comorbid condition on the efficacy of inpatient opioid withdrawal treatment has been underscored. By identifying comorbid ADHD early in the treatment process, tailored therapeutic approaches may help to maximize the effectiveness of interventions and may improve patient outcomes. This underscores the importance of proactive screening for ADHD as a psychiatric comorbidity in optimizing the management of individuals undergoing inpatient opioid withdrawal treatment.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Attention Deficit Hyperactivity Disorder: A Risk Factor for Premature Discontinuation of Inpatient Opioid Withdrawal Treatment

Gaspar,

Kilarski,

Rosen

et al. 2024

JCM

View full text Add to dashboard Cite

show abstract

“…людей на планеті (GATS) [7,26]. За останні роки спостерігається збільшення негативних наслідків від тютюнопаління: захворювання легеневої системи [3], серцево-судинної системи [4,17], онкологічні захворювання [13], порушення пам'яті [9,24], когнітивні, психосоціальні та психіатричні розлади [10,11,14,27], поява суїцидальних думок/спроб, депресій, психологічних розладів [2,5,8,12,18,21,25]. В Україні щороку від тютюнопаління помирають 85 тис.…”

Section: вступunclassified

“…В останні роки велику увагу науковці приділяють негативному впливу вживання канабісу на тривалість, вік, кількість, визначальні фактори несприятливих ефектів на здоров'я людини, на психічне здоров'я особливо молодих людей: зменшення уваги, пам'яті, з появою симптомів психозу, з появою когнітивних, психосоціальних, психіатричних зрушень, появи депресії, суїцидальних думок/спроб у молодих людей [3,4,8,9,10,14,18,24,27].…”

Section: результати обговоренняunclassified

Tobacco smoking among higher medical education students is a real threat today

Чорна¹,

Хлєстова²,

Шевчук³

et al. 2023

Rep. of Vinnytsia Nation. Med. Univ.

View full text Add to dashboard Cite

Annotation. With the help of Google forms, a questionnaire was conducted among applicants of medical institutions of higher education regarding the prevalence, duration, and preferences of types of alternative tobacco products, namely: National Pirogov Memorial Medical University, Vinnytsya (VNMU), Lviv National Medical University named after D. Halytskyi (LNMU), Bukovyna State Medical University (BDMU), Kharkiv National Medical University (KHNMU), National Medical University named after O. O. Bogomolets (NMU), among the five medical higher education institutions of Ukraine. The purpose of the study is to identify the prevalence, duration, causes of smoking, and health threats as consequences of smoking among students of medical institutions of higher education in Ukraine. A content analysis of scientific sources of foreign scientists from many countries of the world regarding the spread of tobacco smoking among student youth in European countries was conducted based on PubMed I Google Scholar databases for the period 2008-2022. Based on the results of the questionnaire, it was determined and compared with the questionnaire of 2019. It was established that among the applicants of medical institutions of higher education I-VI courses – 69.8% (61.2% – in 2019) of students do not smoke, and 30.2% (38.8% – 2019) smoke. Out of them, 76.9% are feminine and 23.1% are masculine. The average age of starting smoking among respondents of medical institutions of higher education was 16 to 18 years old – 21.0%. They use such a bad habit to relieve stress, which accounts for 30.0% of women and 43.6% of men. Cigarettes are preferred by 40.0% of women and 20.0% of men; to cigarettes – by 25.0% of women and 23.3% of men (in 2019 – 48.6%); IQOS – 17.0% of persons of the female article and 6.7% of the persons of the male article; electronic cigarettes – 33.3% of men and 10.0% of women (in 2019 – 10.9%); hookah tobacco – 10.0% among men and 8.0% among women (21.5% in 2019). The solution to the problem of smoking among students of medical institutions of higher education can only be systematic educational measures of anti-nicotine propaganda.

show abstract

“…Numerous studies have revealed a connection between persistent cannabis use during adolescence and an elevated risk of developing psychiatric conditions in adulthood. Specifically, exposure to cannabis during youth moderately heightens the likelihood of experiencing psychotic symptoms [1,59,60]. According to Scholer et al [61], the lifetime prevalence of cannabis-related psychotic symptoms stands at 0.25% for paranoia, 0.15% for the combination of paranoia and hallucinations, and 0.07% for the presence of hallucinations alone.…”

Section: Onset Of Psychosis Anxiety and Depressionmentioning

confidence: 99%

Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View

Padoan,

Colombrino,

Sciorio

et al. 2023

Children

View full text Add to dashboard Cite

Cannabis, a plant known for its recreational use, has gained global attention due to its widespread use and addiction potential. Derived from the Cannabis sativa plant, it contains a rich array of phytochemicals concentrated in resin-rich trichomes. The main cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), interact with CB1 and CB2 receptors, influencing various physiological processes. Particularly concerning is its prevalence among adolescents, often driven by the need for social connection and anxiety alleviation. This paper provides a comprehensive overview of cannabis use, its effects, and potential health risks, especially in adolescent consumption. It covers short-term and long-term effects on different body systems and mental health and highlights the need for informed decision making and public health initiatives, particularly regarding adolescent cannabis use.

show abstract

Cannabis and Psychosis

Cited by 5 publications

References 60 publications

Attention Deficit Hyperactivity Disorder: A Risk Factor for Premature Discontinuation of Inpatient Opioid Withdrawal Treatment

Attention Deficit Hyperactivity Disorder: A Risk Factor for Premature Discontinuation of Inpatient Opioid Withdrawal Treatment

Tobacco smoking among higher medical education students is a real threat today

Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View

Contact Info

Product

Resources

About